Inhibition of Rev-erbα ameliorates muscular dystrophy

Xuekai Xiong1, Hongbo Gao1, Yayu Lin1

  • 1Department of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.

Insights

Loss of Rev-erbα enhances muscle regeneration in Duchenne muscular dystrophy models by promoting myogenic repair and reducing inflammation. This suggests Rev-erbα inhibition as a potential therapy for muscular dystrophy.

Area of Science:

  • Muscle Biology
  • Regenerative Medicine
  • Circadian Biology

Background:

  • Duchenne muscular dystrophy causes progressive muscle degeneration.
  • Enhancing muscle regeneration is a therapeutic strategy.
  • The circadian clock protein Rev-erbα was previously shown to inhibit myogenesis.

Purpose of the Study:

  • To investigate the role of Rev-erbα deficiency in dystrophin-deficient mdx mice.
  • To determine if Rev-erbα loss ameliorates muscular dystrophy pathology.

Main Methods:

  • Utilized dystrophin-deficient mdx mice lacking Rev-erbα.
  • Assessed muscle pathology, regenerative response, and inflammatory markers.
  • Analyzed myoblast differentiation and associated signaling pathways.

Main Results:

  • Rev-erbα deficiency improved dystrophic pathology and reduced muscle wasting in mdx mice.
  • Augmented myogenic response, enhanced neo-myofiber formation, and attenuated inflammation were observed.
  • Loss of Rev-erbα in mdx myoblasts increased differentiation via Wnt signaling and proliferative pathways.

Conclusions:

  • Rev-erbα deficiency protects dystrophic muscle by promoting myogenic repair.
  • Inhibiting Rev-erbα activity shows therapeutic potential for muscular dystrophy.
  • Targeting the circadian clock offers a novel approach for treating muscle degenerative diseases.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
857
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
703